Huawei’s first-half profit drops 32% as tech giant ploughs more money into R&D


Huawei Technologies saw a nearly one-third decline in profit in the first half of the year, despite reclaiming the throne in China’s smartphone market, according to a filing from its shareholding entity Huawei Investment & Holding.

Net profit during the period fell 32 per cent year on year to 37.2 billion yuan (US$5.2 billion), while revenue grew 4 per cent to 427 billion yuan, according to a filing to the Shanghai Clearing House on Friday. Privately owned Huawei regularly discloses its corporate bond issuances to the clearing institution.

Huawei did not offer any explanation for the profit decline, but said first-half expenditure for research and development (R&D) rose 9 per cent to 97 billion yuan, equal to 23 per cent of its revenue. In comparison, the company’s R&D expenditure in the same period last year was equal to 22 per cent of its revenue.

A customer looks at phones in a Huawei store in Shanghai, August 26 2025. Photo: EPA
A customer looks at phones in a Huawei store in Shanghai, August 26 2025. Photo: EPA

From April to June, Huawei regained top spot in the domestic smartphone market for the first time in four years, shipping 12.5 million units to capture 18 per cent market share in the period. However, its shipments were down 3.4 per cent compared with the same period in the previous year, according to market research firm IDC.

China’s smartphone market saw overall shipments drop 4 per cent to 69 million units during that period, the first contraction after six consecutive quarters of growth, IDC data showed.

“This suggests that a significant uplift in smartphone demand is unlikely in the immediate term, and the market will navigate a more complex landscape in the second half of the year,” he said.

  • Related Posts

    China’s securities regulator vows tougher oversight to shore up stock-market confidence

    China’s top securities regulator outlined a plan on Friday to strengthen corporate governance, boost investor returns and cultivate globally competitive companies, as Beijing seeks to reinforce confidence in the country’s…

    Continue reading
    China to pursue commercial health insurance to ease public strain, support drug innovation

    China has for the first time included commercial health insurance in its 2026 government work report, signalling efforts to strengthen the country’s social safety net and support the growth of…

    Continue reading

    Leave a Reply

    Your email address will not be published. Required fields are marked *